NBIX

Neurocrine Biosciences, Inc. News Headlines

$24.49
*  
0.59
2.47%
Get NBIX Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading NBIX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NBIX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Neurocrine Bio. To Present At Oppenheimer Conference; Webcast At 10:55 AM ET
12/10/2014 9:55:00 AM - RTT News


Neurocrine Biosciences Looking Forward To A Big Year
11/6/2014 11:57:00 AM - Seeking Alpha


Neurocrine Biosciences Q3 Loss Widens - Quick Facts
11/3/2014 4:12:00 PM - RTT News


NBIX For The Long Haul, RegeneRx Catches Investors' Eyes, NewLink Inks New Deal
10/20/2014 11:47:00 PM - RTT News


End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies
10/20/2014 7:40:00 AM - Seeking Alpha


KVB Capital LLC's Best And Worst Third-Quarter Performers
10/10/2014 2:42:00 PM - Seeking Alpha


Interesting NBIX Put And Call Options For May 2015
9/25/2014 10:35:01 AM - BNK Invest


Neurocrine Biosciences Moving Ahead With '854
8/9/2014 7:48:00 AM - Seeking Alpha


2 Biotechs Race To Treat Movement Disorders
6/27/2014 8:00:00 AM - Seeking Alpha


Neurocrine In "Hurry Up And Wait" Mode
6/11/2014 5:18:00 PM - Seeking Alpha


Neurocrine Biosciences (NBIX) Shares Cross Below 200 DMA
4/10/2014 10:35:04 AM - BNK Invest


Fundamentals Continue To Look Strong At Neurocrine Bio
2/8/2014 9:47:00 AM - Seeking Alpha


Kinect-2 Puts '854 Back Into Play For Neurocrine
1/8/2014 9:50:00 AM - Seeking Alpha


Increasing Price Target On Neurocrine Bio After Phase 2 Success
1/8/2014 9:34:00 AM - Seeking Alpha


Mid-Afternoon Market Update: Markets Post Large Rally as Textron Falls on Citron Report
1/7/2014 3:43:33 PM - Benzinga


Mid-Morning Market Update: Markets Open Higher; IHS Profit Beats Estimates
1/7/2014 11:38:16 AM - Benzinga


Pre-Market Most Active for Jan 7, 2014 : SIRI, SAN, BAC, GRPN, FB, NYMT, NBIX, SNY, SD, ALU, P, DRYS
1/7/2014 8:39:55 AM - NASDAQ.com News


After Hours Most Active for Jan 6, 2014 : HD, QQQ, XRX, DF, WWAV, PFE, BAC, MSFT, INTC, CSCO, NBIX, MDLZ
1/6/2014 4:42:35 PM - NASDAQ.com News


Look For These Biotech Stocks To Move In 2014
12/19/2013 11:14:00 AM - Seeking Alpha


Neurocrine Biosciences, Inc. Enters Oversold Territory - Tale of the Tape
11/4/2013 6:33:46 AM - Zacks.com


Neurocrine Will Get Second Chance To Offer Up VMAT-2 Data In December
10/30/2013 3:42:00 PM - Seeking Alpha


Sector Update: Biotechnology Stocks Showing The Way On NASDAQ
10/1/2013 12:44:44 PM - MT Newswires


Why AbbVie Is A Solid Buy
9/19/2013 5:56:00 PM - Seeking Alpha


AbbVie Has Excellent Management Efficiency, But Is It A Buy?
9/13/2013 2:47:00 AM - Seeking Alpha


Neurocrine And ChemoCentryx: Phase II Data Disappoints
9/11/2013 10:48:00 AM - Seeking Alpha